Adiponectin and adiponectin receptors in human pheochromocytoma

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 442-447

  Isobe, Kazumasa ^a   Fu, Ling ^a   Tatsuno, Ichirou ^b   Takahashi, Hideto ^a   Nissato, Sumiko ^a   Hara, Hisato ^a   Yashiro, Toru ^a   Suzukawa, Kazumi ^a   Takekoshi, Kazuhiro ^a   Shimano, Hitoshi ^a   Kawakami, Yasushi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Adiponectin receptors; Adrenaline; Diabetes; Pheochromocytoma

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ADRENALIN; CATECHOLAMINE; MESSENGER RNA; NORADRENALIN;

ADRENALECTOMY; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR WEIGHT; PHEOCHROMOCYTOMA; SIGNAL TRANSDUCTION;

EID: 73249130789     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.No885     Document Type: Article

References (18)

1. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocrine Reviews, 2005; 26: 439-451
2. Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S: Decreased plasma adiponectin levels in young obese males. Journal of Atherosclerosis and Thrombosis, 2003; 10: 234-238
3. Katsuda Y, Asano A, Murase Y, Chujo D, Yagi K, Kobayashi J, Mabuchi H, Yamagishi M: Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. Journal of Atherosclerosis and Thrombosis, 2007; 14: 19-26
4. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K: Adiponectin and adiponectin receptors insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest, 2006; 116: 1784-1792
5. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett, 2001; 507: 142-146
6. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y: β-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-α expression in adipocyte. Eur J Pharmacol, 2007; 569: 155-162
7. Turnbull DM, Johnston DG, Alberti KGMM, Hall R: Hormonal and metabolic studies in a patient with pheochromocytoma. J Clin Endocrinol Metab, 1980; 51: 930-933
8. Stenström G, Sjöström L, Smith U: Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol (Copenh), 1984;106: 511-515
9. La Batide-Alanore A, Chatellier G, Plouin PF: Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertension, 2003; 21: 1703-1707
10. Wiesner TD, Blüher M, Windgassen M, Pascheke R: Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab, 2003; 88: 3632-3636
11. Hamaji M: Pancreatic α- and β- cells function in pheochromocytoma. J Clin Endocrinol Metab, 1979; 49: 322-325
12. Blüher M, Windgassen M, Paschke R: Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care, 2000; 23: 1591-1592
13. Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest, 1980; 65: 717-721
14. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med, 1980; 303: 436-444
15. Clutter WE, Bier DM, Shah SD, Cryer PE: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest, 1980; 66: 94-101
16. Niklasson M, Holmäng A, Lönnroth P: Induction of rat muscle insulin resistance by epinephrine is accompanied by increased interstitial glucose and lactate concentrations. Diabetologia, 1998; 41: 1467-1473
17. Ermetici F, Malavazos AE, Corbetta S, Morricone L, Dall'Asta C, Corsi MM, Ambrosi B: Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism, 2007; 56: 686-692
18. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T: Target disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med, 2007; 13: 332-339